In addition to the 21 proteins that have been already associated with at least one drug, we found a further 4 potential drug targets that mapped to druggable CATH-FunFams and were upregulated in cancer based on our gene expression analysis (NR1H2, NR1H3, NR5A1, THRB). This evidence concerns the gene NR5A1 and cancer.